Published in Blood Weekly, March 13th, 1995
Weiming Xu, The Scripps Research Institute, La Jolla, California, and colleagues stated that mutations producing G6PD deficiency have been identified in samples from patients with hemolytic disease in the United States as well as in G6PD-deficient samples from Greece, the Canary Islands, the Czech and Slovak Republics, South China and in samples from the Coriell Cell Repository.
The researchers noted that G6PD deficiency probably is the most common enzymopathy in humans. The deficiency results in neonatal jaundice, drug-induced hemolytic anemia,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1995-03-13)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.